GUFICBIO — Gufic Biosciences Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹33.98bn
- IN₹37.18bn
- IN₹8.07bn
- 31
- 11
- 78
- 31
Annual cashflow statement for Gufic Biosciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
R2020 March 31st | 2021 March 31st | C2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 227 | 442 | 958 | 797 | 861 |
| Depreciation | |||||
| Non-Cash Items | 108 | 145 | 42.5 | 73.6 | 171 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -2.19 | 140 | -128 | -1,359 | -1,277 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Taxes Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 471 | 891 | 1,062 | -266 | -74.6 |
| Capital Expenditures | -398 | -142 | -875 | -1,876 | -1,127 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -26.8 | 57.1 | -71.4 | -31.3 | 103 |
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -425 | -85.1 | -946 | -1,907 | -1,024 |
| Financing Cash Flow Items | -137 | -134 | -50.3 | -81.2 | -152 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -42.1 | -786 | -62.4 | 2,343 | 824 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 3.65 | 19.4 | 54.1 | 170 | -275 |